Unnamed: 0,title,date,stock,sentiment
235862.0,"Gives His Opinion On GM, American Airlines And More",2020-04-29 09:44:00-04:00,CHE,neutral
235863.0,"Chemed Q1 Adj. EPS $3.680 Beats $3.650 Estimate, Sales $516.000M Miss $520.180M Estimate",2020-04-28 16:17:00-04:00,CHE,negative
235864.0,"Earnings Scheduled For April 28, 2020",2020-04-28 04:55:00-04:00,CHE,neutral
235865.0,Chemed Adds $250M To Buyback,2020-03-13 11:31:00-04:00,CHE,neutral
235866.0,"RBC Capital Upgrades Chemed to Outperform, Raises Price Target to $535",2020-03-11 06:41:00-04:00,CHE,neutral
235867.0,Stocks That Hit 52-Week Highs On Wednesday,2020-02-19 10:32:00-05:00,CHE,neutral
235868.0,"Oppenheimer Maintains Outperform on Chemed, Raises Price Target to $535",2020-02-19 09:34:00-05:00,CHE,neutral
235869.0,"Chemed Q4 Adj. EPS $4.22 Beats $4.09 Estimate, Sales $522M Miss $524.19M Estimate",2020-02-18 16:16:00-05:00,CHE,negative
235870.0,"Earnings Scheduled For February 18, 2020",2020-02-18 04:23:00-05:00,CHE,neutral
235871.0,Stocks That Hit 52-Week Highs On Wednesday,2020-02-12 11:45:00-05:00,CHE,neutral
235872.0,Stocks That Hit 52-Week Highs On Friday,2020-01-17 13:23:00-05:00,CHE,neutral
235873.0,Stocks That Hit 52-Week Highs On Thursday,2020-01-16 10:22:00-05:00,CHE,neutral
235874.0,Stocks That Hit 52-Week Highs On Wednesday,2020-01-15 13:14:00-05:00,CHE,neutral
235875.0,Stocks That Hit 52-Week Highs On Thursday,2020-01-09 15:15:00-05:00,CHE,neutral
235876.0,Stocks That Hit 52-Week Highs On Monday,2019-12-16 10:16:00-05:00,CHE,neutral
235877.0,"Oppenheimer Maintains Perform on Chemed, Raises Price Target to $470",2019-11-25 09:38:00-05:00,CHE,neutral
235878.0,"Benzinga's Top Upgrades, Downgrades For Npvember 1, 2019",2019-11-01 09:45:00-04:00,CHE,positive
235879.0,"JMP Securities Upgrades Chemed to Market Outperform, Announces $490 Price Target",2019-11-01 06:13:00-04:00,CHE,positive
235880.0,"Chemed Q3 Adj. EPS $3.46 Beats $3.31 Estimate, Sales $480.613M Beat $478.89M Estimate",2019-10-29 16:55:00-04:00,CHE,neutral
235881.0,Chemed's Roto-Rooter Services Acquires All Of Hoffman Southwest Corporation's Roto-rooter Franchise Operations For A Purchase Price Of $120 Million,2019-09-16 12:20:00-04:00,CHE,neutral
235882.0,Stocks That Hit 52-Week Highs On Wednesday,2019-08-21 10:17:00-04:00,CHE,neutral
235883.0,Stocks That Hit 52-Week Highs On Tuesday,2019-08-20 10:27:00-04:00,CHE,neutral
235884.0,A List Of Stocks Reaching New 52-Week Highs,2019-08-09 10:29:00-04:00,CHE,positive
235885.0,Stocks That Set New 52-Week Highs Thursday,2019-08-08 12:19:00-04:00,CHE,neutral
235886.0,New 52-Week-High Achievers For Tuesday Morning,2019-08-06 10:23:00-04:00,CHE,neutral
235887.0,Stocks That Achieved 52-Week Highs Monday Morning,2019-08-05 12:40:00-04:00,CHE,neutral
235888.0,Chemed Raises FY2019 EPS Guidance from $12.65-12.85 to $13.65-13.85 vs $13.22 Est,2019-08-05 08:06:00-04:00,CHE,neutral
235889.0,Chemed's Roto-Rooter to Acquire its Largest Independent Franchise Operator for $120M,2019-08-05 07:02:00-04:00,CHE,neutral
235890.0,Stocks That Managed to Breach 52-Week Highs Wednesday Morning,2019-07-31 11:01:00-04:00,CHE,neutral
235891.0,New Stocks that Broke Through 52-Week Highs Tuesday Morning,2019-07-30 10:34:00-04:00,CHE,negative
235892.0,New Equities that Broke Through 52-Week Highs Monday Morning,2019-07-29 10:13:00-04:00,CHE,negative
235893.0,Companies That Achieved 52-Week Highs Friday,2019-07-26 15:37:00-04:00,CHE,neutral
235894.0,"Chemed Q2 Adj. EPS $3.36 Beats $3.11 Estimate, Sales $474M Beat $471.72M Estimate",2019-07-25 16:22:00-04:00,CHE,neutral
235895.0,Shares of several healthcare companies are trading lower on continued uncertainty over healthcare policy as well as concerns over the medicare-for-all proposals among 2020 candidates.,2019-04-30 12:16:00-04:00,CHE,negative
235896.0,Chemed Sees FY19 Adj. EPS $12.65-$12.85 vs $12.78 Est.; Sees $10M For Medicare Cap Billing Limitations In 2019,2019-04-29 16:58:00-04:00,CHE,neutral
235897.0,"Chemed Q1 Adj. EPS $2.92 Misses $2.96 Estimate, Sales $462.034M Miss $468.28M Estimate",2019-04-29 16:56:00-04:00,CHE,negative
235898.0,"Earnings Scheduled For April 29, 2019",2019-04-29 04:28:00-04:00,CHE,neutral
235899.0,"RBC Capital Maintains Sector Perform on Chemed, Raises Price Target to $318",2019-02-25 09:38:00-05:00,CHE,neutral
235900.0,Chemed Corporation Announces That The Board Of Directors Has Formally Authorized An Additional $150 Million For Stock Repurchase Under Chemed's Existing Share Repurchase Program,2019-02-25 08:33:00-05:00,CHE,positive
235901.0,Chemed Adds $150M To Buyback,2019-02-25 08:30:00-05:00,CHE,neutral
235902.0,"Chemed Q4 Adj. EPS $3.35 Beats $3.26 Estimate, Sales $457.507M Miss $460.5M Estimate",2019-02-20 17:15:00-05:00,CHE,negative
235903.0,"Earnings Scheduled For February 20, 2019",2019-02-20 04:04:00-05:00,CHE,neutral
235904.0,"Stocks Trading Ex Dividend For Thurs., Nov. 8, 2018",2018-11-08 10:55:00-05:00,CHE,neutral
235905.0,64 Biggest Movers From Yesterday,2018-10-31 05:00:00-04:00,CHE,neutral
235906.0,55 Stocks Moving In Tuesday's Mid-Day Session,2018-10-30 13:32:00-04:00,CHE,neutral
235907.0,Chemed shares are trading up 8.9% after the company beat Q3 EPS and raised FY18 guidance.,2018-10-30 13:07:00-04:00,CHE,positive
235908.0,Chemed Corporation Late Monday Raised FY18 Adj. EPS Guidance From $10.60-$10.85 To $11.80-$11.90 vs $11.47 Est.,2018-10-30 13:06:00-04:00,CHE,neutral
235909.0,"Chemed Q3 EPS $3.07 Beats $2.80 Estimate, Sales $444.151M Miss $445.16M Estimate",2018-10-29 16:19:00-04:00,CHE,negative
235910.0,"Earnings Scheduled For October 29, 2018",2018-10-29 04:37:00-04:00,CHE,neutral
235911.0,"Benzinga's Top Upgrades, Downgrades For October 12, 2018",2018-10-12 09:13:00-04:00,CHE,positive
235912.0,"Bank of America Initiates Coverage On Chemed with Buy Rating, Announces $390 Price Target",2018-10-12 07:25:00-04:00,CHE,neutral
235913.0,"Chemed Corporation Subsidiary, Roto-Rooter, Acquires Five Northern California Franchises",2018-10-01 12:33:00-04:00,CHE,neutral
235914.0,Chemed Raises Qtr. Dividend From $0.28 To $0.30/Share,2018-08-03 11:21:00-04:00,CHE,neutral
235915.0,Chemed Sees FY18 Adj. EPS $11.35-$11.55 vs $11.16 Est.,2018-07-25 16:39:00-04:00,CHE,neutral
235916.0,"Chemed Q2 EPS $2.81 Beats $2.77 Estimate, Sales $442M Beat $434.27M Estimate",2018-07-25 16:39:00-04:00,CHE,neutral
235917.0,"Jefferies Global Healthcare Begins Today, Presenters Include: Kadmon, Aeri Pharma, Chemed, Orthofix, Revance, Heron Therapeutics, and Dicerna Pharma",2018-06-05 08:55:00-04:00,CHE,neutral
235918.0,Chemed Reaffirms FY18 Outlook; Says Will Update Guidance During 2H'18 When Q2 Earnings Reported,2018-04-19 16:16:00-04:00,CHE,neutral
235919.0,"Chemed Q1 Adj. EPS $2.72 Beats $2.36 Est., Sales $439M Beats $419.3M Est.",2018-04-19 16:15:00-04:00,CHE,neutral
235920.0,"Earnings Scheduled For April 19, 2018",2018-04-19 04:08:00-04:00,CHE,neutral
235921.0,Chemed Board Authorizes Add'l $150M Stock Buyback,2018-03-06 11:59:00-05:00,CHE,neutral
235922.0,"RBC Capital Global Healthcare Conference Begins Today, Presenters Include: Chemed, Revance, Eagle Pharma, Enanta, Gilead, TransEnterix, Immunogen, and Incyte",2018-02-21 07:14:00-05:00,CHE,neutral
235923.0,Chemed Sees FY18 Adj. EPS $10.60-$10.85 vs $10.01 Est.,2018-02-14 16:53:00-05:00,CHE,neutral
235924.0,"Chemed Reports Q4 Adj. EPS $2.32 vs $2.27 Est., Sales $428M vs $423M Est.",2018-02-14 16:52:00-05:00,CHE,neutral
235925.0,4 Growth Stocks To Pick From A Choppy MedTech Market,2017-12-14 12:35:00-05:00,CHE,positive
235926.0,"Chemed Settles DOJ Litigation, Co. Will Pay The U.S. And State Of Illinois $75.5M Plus Interest And Agreed To Certain Attorney Fees Bringing Total Settlement To $85M; No Admission Or Determination Of Wrongdoing",2017-10-31 11:25:00-04:00,CHE,positive
235927.0,"Chemed Reports Q3 Adj. EPS $2.15 vs $2.01 Est., Sales $417M vs $413.83M Est.",2017-10-26 16:50:00-04:00,CHE,neutral
235928.0,KeyBanc Initiates Coverage On Chemed with Sector Weight Rating,2017-08-28 05:59:00-04:00,CHE,neutral
235929.0,Chemed Raises Qtr. Dividend From $0.26 To $0.28/Share,2017-08-04 12:10:00-04:00,CHE,neutral
235930.0,UPDATE: Chemed Raises FY17 Outlook: EPS From $7.80-$8 To $8.10-$8.20 vs $7.95 Est.,2017-07-25 16:37:00-04:00,CHE,neutral
235931.0,Chemed Raises FY17 Outlook,2017-07-25 16:35:00-04:00,CHE,neutral
235932.0,"Chemed Reports Q2 Adj. EPS $2.15 vs $1.89 Est., Sales $415M vs $407M Est.",2017-07-25 16:34:00-04:00,CHE,neutral
235933.0,"Bank Of America Health Care Conference Concludes Today; Presenters Include Boston Scientific, Humana, Universal Health, Chemed, Community Health, Eagle Pharma, Alnylam, Gilead, & Illumina",2017-05-18 08:53:00-04:00,CHE,positive
235934.0,Chemed Sees FY17 Adj. EPS $7.80-$8.00 vs $7.90 Est.,2017-04-26 16:18:00-04:00,CHE,neutral
235935.0,"Chemed Reports Q1 Adj. EPS $1.82 vs $1.79 Est., Sales $406M vs $399M Est.",2017-04-26 16:17:00-04:00,CHE,neutral
235936.0,Chemed  Sees FY17 Adj. EPS $7.80-$8.00 vs. $7.80 Est.,2017-02-15 16:16:00-05:00,CHE,neutral
235937.0,"Chemed Reports Q4 Adj. EPS $2.10 vs. $2.10 Est., Rev. $403M vs. $409M Est.",2017-02-15 16:15:00-05:00,CHE,neutral
235938.0,Chemed Sees FY16 EPS $7.20-$7.30 vs $7.25 Est.,2016-10-26 16:57:00-04:00,CHE,neutral
235939.0,"Chemed Reports Q3 Adj. EPS $1.73 vs $1.82 Est., Sales $393M vs $397M Est.",2016-10-26 16:56:00-04:00,CHE,neutral
235940.0,Chemed Increases Quarterly Dividend 8.3% To $0.26/Share,2016-08-05 12:11:00-04:00,CHE,neutral
235941.0,Compass Minerals International Trading Down 2.88% After Missing Revenue Estimates By ~9M,2016-07-25 16:32:00-04:00,CHE,negative
235942.0,Chemed Corp Down 1.14% After Missing Revenue Estimates,2016-07-25 16:30:00-04:00,CHE,negative
235943.0,Chemed Sees FY16 Adj. EPS $7.15-$7.30 vs $7.18 Est.,2016-07-25 16:16:00-04:00,CHE,neutral
235944.0,"Chemed Reports Q2 EPS $1.80 vs. Est. $1.72, Rev. $390M vs. Est. $394M",2016-07-25 16:15:00-04:00,CHE,neutral
235945.0,"Earnings Scheduled For July 25, 2016",2016-07-25 04:55:00-04:00,CHE,neutral
235946.0,Chemed Corp CEO Timothy O'Toole To Retire,2016-06-08 17:02:00-04:00,CHE,neutral
235947.0,"Chemed Corporation Announces the Retirement of CEO Timothy S. O'Toole, Will Remain On-Board As Consultant",2016-06-08 17:02:00-04:00,CHE,neutral
235948.0,"UPDATE: Chemed Sees FY16 ADj. EPS Excluding Non-Cash Expense for Stock Options, Costs Related to Litigation $7.05-$7.25 vs $7.13 Est.",2016-04-28 17:14:00-04:00,CHE,negative
235949.0,Chemed Sees FY16 Adj. EPS $7.61-$7.81,2016-04-28 17:13:00-04:00,CHE,neutral
235950.0,"Chemed Reports Q1 Adj. EPS $1.62 vs $1.58 Est., Sales $390M vs $391.7M Est.",2016-04-28 17:12:00-04:00,CHE,neutral
235951.0,Chemed Announces Added $100M Buyback Plan,2016-03-14 08:01:00-04:00,CHE,neutral
235952.0,Chemed Sees FY16 EPS $7.05-$7.25 vs. Est. $7.31,2016-02-17 16:56:00-05:00,CHE,neutral
235953.0,"Chemed Reports Q4 EPS $1.97 vs. Est. $1.81, Rev. $399M vs. Est. $390.22M",2016-02-17 16:55:00-05:00,CHE,neutral
235954.0,"Worst Performing Industries For November 9, 2015",2015-11-09 11:09:00-05:00,CHE,negative
235955.0,Chemed Sees FY15 Adj. EPS $6.75-$6.80 vs $6.75 Est.,2015-10-22 16:22:00-04:00,CHE,neutral
235956.0,"Chemed Reports Q3 Adj. EPS $1.78 vs $1.61 Est., Sales $386M vs $376M Est.",2015-10-22 16:22:00-04:00,CHE,neutral
235957.0,"In Any Economy, This Motif Is To Die For",2015-09-24 14:16:00-04:00,CHE,negative
235958.0,10% Annual Alpha? Why Pair Trades Make Sense When The Market Is Volatile,2015-09-14 13:31:00-04:00,CHE,neutral
235959.0,Chemed Corp. Raises Qtr. Dividend from $0.22 to $0.24/Share,2015-08-07 12:08:00-04:00,CHE,neutral
235960.0,Stocks Hitting 52-Week Highs,2015-07-27 10:07:00-04:00,CHE,neutral
235961.0,"Chemed Reports Q2 EPS $1.55 Vs Est $1.59, Sales $382M Vs Est $373.61M",2015-07-23 16:38:00-04:00,CHE,neutral
235962.0,Top 4 Stocks In The Home Health Care Industry With The Highest Operating Margin,2015-05-26 04:35:00-04:00,CHE,positive
235963.0,Chemed Sees FY Adj. EPS $6.50-$6.70 vs $6.57 Est.,2015-04-28 16:25:00-04:00,CHE,neutral
235964.0,"Chemed Reports Q1 Adj EPS $1.54 Vs Est $1.44, Sales $376.7M Vs Est $370.76M",2015-04-28 16:05:00-04:00,CHE,neutral
235965.0,Top 4 Stocks In The Home Health Care Industry With The Highest EPS,2015-02-27 04:12:00-05:00,CHE,positive
235966.0,"Top Performing Industries For February 18, 2015",2015-02-18 10:31:00-05:00,CHE,positive
235967.0,"Chemed Reports Q4 Adj. EPS $1.80 vs $1.70 Est., Sales $379.4M vs $372.8M Est.",2015-02-17 16:04:00-05:00,CHE,neutral
235968.0,"Earnings Scheduled For February 17, 2015",2015-02-17 04:46:00-05:00,CHE,neutral
235969.0,Chemed Corp. Sees FY2014 EPS $6.00-6.05,2014-10-30 16:04:00-04:00,CHE,neutral
235970.0,Chemed Corp. Reports Q3 EPS of $1.48 vs $1.51 Est; Revenue of $358.40M vs $359.88M Est,2014-10-30 16:03:00-04:00,CHE,neutral
235971.0,Top 4 Small-Cap Stocks In The Home Health Care Industry With The Highest Profit Margin,2014-10-08 05:12:00-04:00,CHE,positive
235972.0,Top 4 Stocks In The Home Health Care Industry With The Highest ROE,2014-09-05 04:52:00-04:00,CHE,positive
235973.0,Top 4 Stocks In The Home Health Care Industry With The Highest Profit Margin,2014-08-27 04:57:00-04:00,CHE,positive
235974.0,Chemed Raises Qtr. Dividend from $0.20 to $0.22/Share,2014-08-08 11:48:00-04:00,CHE,neutral
235975.0,Chemed Corp. Sees FY2014 EPS $5.90-6.10 vs $5.88 Est,2014-07-23 16:30:00-04:00,CHE,neutral
235976.0,Chemed Corp. Reports Q2 EPS of $1.50 vs $1.47 Est; Revenue of $360.0M vs $363.73M Est,2014-07-23 16:27:00-04:00,CHE,neutral
235977.0,Chemed Corp. Sees FY2014 EPS $5.90-6.10 vs $5.90 Est,2014-04-29 16:13:00-04:00,CHE,neutral
235978.0,"Chemed Corp. Reports Q1 EPS of $1.32, Inline; Revenue of $358.30M vs $356.77M Est",2014-04-29 16:12:00-04:00,CHE,neutral
235979.0,Chemed Reports Q4 Adjusted EPS of $1.45 vs $1.46 Est; Revenue of $349.0M vs $358.61M Est,2014-02-17 22:20:00-05:00,CHE,neutral
235980.0,"Deutsche Bank Maintains Hold on Chemed Corp., Raises PT to $64.00",2013-10-30 07:27:00-04:00,CHE,neutral
235981.0,Chemed Corp. Sees FY2013 EPS $5.60-5.65 vs $5.67 Est,2013-10-28 16:22:00-04:00,CHE,neutral
235982.0,Chemed Corp. Reports Q3 EPS of $0.94 vs $1.34 Est; Revenue of $340.90M vs $355.40M Est,2013-10-28 16:21:00-04:00,CHE,neutral
235983.0,"Deutsche Bank Maintains Hold on Chemed Corp., Lowers PT to $63.00",2013-09-10 07:38:00-04:00,CHE,negative
235984.0,Chemed Raises Qtr. Dividend from $0.18 to $0.20/Share,2013-08-02 12:36:00-04:00,CHE,neutral
235985.0,CL King Downgrades Chemed Corp. to Neutral,2013-07-19 09:35:00-04:00,CHE,neutral
235986.0,"Oppenheimer Maintains Outperform on Chemed Corp., Lowers PT to $85.00",2013-06-11 10:40:00-04:00,CHE,negative
235987.0,Citron Negative on Chemed,2013-05-10 12:54:00-04:00,CHE,negative
235988.0,Chemed Announces Receipt of False Claims Action Complaint,2013-05-03 11:23:00-04:00,CHE,negative
235989.0,"Deutsche Bank Maintains Hold on Chemed Corp., Raises PT to $80.00",2013-04-19 08:19:00-04:00,CHE,neutral
235990.0,Chemed Corp. Reports Q1 EPS of $1.38 vs $1.28 Est; Revenue of $367.0M vs $365.08M Est,2013-04-18 16:07:00-04:00,CHE,neutral
235991.0,Top 4 Small-Cap Stocks In The Home Health Care Industry With The Highest Cash,2013-04-09 04:16:00-04:00,CHE,positive
235992.0,Chemed Adds $100M to Buyback Plan,2013-02-20 13:15:00-05:00,CHE,neutral
235993.0,Chemed Corp. Reports Q4 EPS of $1.57 vs $1.48 Est; Revenue of $369.0M vs $364.95M Est,2013-02-18 17:52:00-05:00,CHE,neutral
235994.0,Chemed 10-Q Shows Subpoena from Florida AG ,2012-11-02 09:53:00-04:00,CHE,neutral
235995.0,"UPDATE: Deutsche Bank Reiterates Hold Rating, Raises PT on Chemed Corporation",2012-10-31 12:51:00-04:00,CHE,neutral
235996.0,CL King Downgrades Chemed from Strong Buy to Buy,2012-10-31 11:05:00-04:00,CHE,positive
235997.0,"Deutsche Bank Maintains Chemed at Hold, Raises PT from $67 to $70",2012-10-31 08:25:00-04:00,CHE,neutral
235998.0,"Chemed Guides FY12 EPS $5.20-5.30, Ha Seen $5.35-5.50",2012-10-29 14:28:00-04:00,CHE,positive
235999.0,Chemed Reports Q3 EPS $1.28 vs $1.35 Est; Revenues $354M vs $360.64M Est,2012-10-29 14:12:00-04:00,CHE,neutral
236000.0,"UPDATE: Oppenheimer Holdings Reiterates Outperform Rating, Raises PT on Chemed Corporation",2012-10-03 11:05:00-04:00,CHE,neutral
236001.0,"Oppenheimer Maintains Chemed at Outperform, Raises PT from $75 to $80",2012-10-03 06:47:00-04:00,CHE,neutral
236002.0,Chemed Corporation Increases Quarterly Dividend to 18 cents from 16 cents,2012-08-03 13:40:00-04:00,CHE,neutral
236003.0,Chemed Reports Q2 EPS $1.26 vs $1.26 Est; Revenues $354M vs $353.61M Est,2012-07-25 16:28:00-04:00,CHE,neutral
236004.0,Top 4 Stocks In The Home Health Care Industry With The Highest ROE,2012-05-18 04:33:00-04:00,CHE,positive
236005.0,Chemed Guides 2012 EPS $5.35-5.50 vs $5.49 Est,2012-04-19 16:27:00-04:00,CHE,neutral
236006.0,Chemed Reports Q1 EPS $1.21 vs $1.28 Est; Revenues $352.9M vs $350.25M Est,2012-04-19 16:03:00-04:00,CHE,neutral
236007.0,Top 4 Small-Cap Stocks In The Home Health Care Industry With The Highest Operating Margin,2012-04-19 03:16:00-04:00,CHE,positive
236008.0,Top 4 Stocks In The Home Health Care Industry With The Lowest PEG Ratio,2012-03-27 04:20:00-04:00,CHE,positive
236009.0,"St. Jude, Novo Nordisk and Other Health Care Stocks Worth a Look Now",2012-03-21 07:20:00-04:00,CHE,positive
236010.0,Top 4 Stocks In The Home Health Care Industry With The Highest ROE,2012-03-12 04:48:00-04:00,CHE,positive
236011.0,UPDATE: Deutsche Bank Raises Target on Chemed Corp to $67,2012-02-16 07:57:00-05:00,CHE,neutral
236012.0,Chemed Reports Q4 EPS $1.45 vs $1.43 Est; Revenues $350.00M vs $353.47M Est	 			,2012-02-14 16:01:00-05:00,CHE,neutral
236013.0,Earnings Scheduled For February 14,2012-02-14 03:58:00-05:00,CHE,neutral
236014.0,Notable Put Options Activity in Chemed,2011-11-16 15:48:00-05:00,CHE,neutral
236015.0,Oppenheimer Maintains Hold on Chemed Pending Details of Lawsuit,2011-11-16 11:30:00-05:00,CHE,negative
236016.0,Chemed Corporation's Board of Directors Authorizes $100 Million Stock Repurchase Program,2011-11-07 07:30:00-05:00,CHE,neutral
236017.0,Oppenheimer Maintains Outperform Rating and $75 PT on Chemed Corporation ,2011-10-26 07:46:00-04:00,CHE,neutral
236018.0,Chemed Sees Year End EPS $4.75-$4.85 vs $4.31 Est,2011-10-25 16:16:00-04:00,CHE,neutral
236019.0,Chemed Guides 2011 EPS $4.75-4.85 vs $4.31 Est; Revenues +4.5% to +5.5%,2011-10-25 16:15:00-04:00,CHE,neutral
236020.0,Chemed Corp Reports Q3 EPS $1.04 vs $1.10 Est; Revenues $341M vs $342.92M Est			,2011-10-25 16:14:00-04:00,CHE,neutral
236021.0,Top 4 Small-Cap Stocks In The Home Health Care Industry With The Highest Operating Margin,2011-08-17 04:16:00-04:00,CHE,positive
236022.0,Chemed Corporation Increases Quarterly Dividend by 14.3% to $0.16,2011-08-08 07:30:00-04:00,CHE,neutral
236023.0,Chemed Corp Reports Q2 EPS of $1.09 vs. $1.07 Est; Revenues $333 vs. $336.35M Est			,2011-07-26 16:11:00-04:00,CHE,neutral
236024.0,Top Performing Industries For June 15,2011-06-15 10:14:00-04:00,CHE,positive
236025.0,VITAS Healthcare Corporation Acquires Family Comfort Hospice; Terms Not Disclosed   ,2011-05-02 11:09:00-04:00,CHE,positive
236026.0,VITAS Healthcare Corporation Acquires Hospice in Alabama; Terms not Disclosed,2011-05-02 07:33:00-04:00,CHE,neutral
236027.0,"Top Performing Industries For April 26 (SIFY, CRDN, CHE, IIVI)",2011-04-26 10:08:00-04:00,CHE,positive
236028.0,Chemed Corp Reports EPS of $1.07 vs. $0.98 Estimate; Revenues $331M vs. $329.3M Estimate,2011-04-25 16:01:00-04:00,CHE,neutral
236029.0,"Top 4 Small-Cap Stocks In The Home Health Care Industry With The Highest ROE (LHCG, AFAM, CHE, AMED)",2011-04-19 01:11:00-04:00,CHE,positive
236030.0,Chemed Corporation Announces a Five-Year $350M Credit Agreement ,2011-03-01 14:09:00-05:00,CHE,positive
236031.0,Chemed Corporation Announces $100M Share Buyback,2011-02-22 07:30:00-05:00,CHE,positive
236032.0,Chemed Reports Q4 EPS of $0.98 vs. $1.05,2011-02-15 16:43:00-05:00,CHE,neutral
236033.0,Chemed Reports Fourth-Quarter 2010 Results,2011-02-15 16:17:00-05:00,CHE,neutral
236034.0,Deutsche Bank Gives Update On Chemed Corp.; Raises PT,2011-01-18 09:14:00-05:00,CHE,neutral
236035.0,Deutsche Bank Raises PT On Chemed Corporation,2011-01-18 07:22:00-05:00,CHE,neutral
236036.0,JMP Securities Downs CHE To Market Perform,2011-01-03 06:54:00-05:00,CHE,positive
236037.0,Chemed Going For Another $70M In Share Repurchase,2010-12-28 08:09:00-05:00,CHE,positive
236038.0,Chemed Board of Directors Approves $70M Stock Buyback (CHE),2010-12-27 16:10:00-05:00,CHE,positive
236039.0,Chemed Corporation Approves $70 Million Stock Repurchase Program ,2010-12-27 16:07:00-05:00,CHE,positive
236040.0,"Top 4 Small-Cap Stocks In The Home Health Care Industry With The Highest Cash (CHE, AMED, GTIV, AFAM)",2010-12-17 03:43:00-05:00,CHE,positive
236041.0,Chemed Corporation Declares Quarterly Dividend of 14 Cents ,2010-11-12 13:13:00-05:00,CHE,neutral
236042.0,RBC Capital Changing Price Targets,2010-10-27 13:01:00-04:00,CHE,neutral
236043.0,Chemed Corp Q310 EBITDA Comes In Ahead Of Oppenheimer Estimates,2010-10-26 09:29:00-04:00,CHE,neutral
236044.0,Chemed Reports Third-Quarter Results   ,2010-10-25 16:05:00-04:00,CHE,neutral
236045.0,"Top 4 Stocks In The Home Health Care Industry With The Highest Cash (GTIV, LNCR, CHE, AMED)",2010-06-23 07:22:00-04:00,CHE,positive
236046.0,"Top 4 Small-Cap Stocks In The Home Health Care Industry With The Highest Return On Equity (AMED, CHE, GTIV, LHCG)",2010-06-23 07:18:00-04:00,CHE,positive
236047.0,"Benzinga’s Top Downgrades (PAET, RES, VCLK, CHE, PAAS)",2010-02-17 14:18:00-05:00,CHE,positive
236048.0,Chemed Corp. (CHE) Earnings Beat Expectations,2010-02-15 22:42:00-05:00,CHE,neutral
236049.0,EX-DIVIDEND,2009-11-17 08:44:00-05:00,CHE,neutral
236050.0,Basilea reports 2009 interim results,2009-08-14 01:21:00-04:00,CHE,neutral
